BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

366 related articles for article (PubMed ID: 11129412)

  • 1. Functions of the VEGF/VEGF receptor system in the vascular system.
    Breier G
    Semin Thromb Hemost; 2000; 26(5):553-9. PubMed ID: 11129412
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lymphatic versus blood vascular endothelial growth factors and receptors in humans.
    Partanen TA; Paavonen K
    Microsc Res Tech; 2001 Oct; 55(2):108-21. PubMed ID: 11596156
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vascular endothelial growth factor (VEGF) and its effect on angiogenesis.
    Jośko J; Gwóźdź B; Jedrzejowska-Szypułka H; Hendryk S
    Med Sci Monit; 2000; 6(5):1047-52. PubMed ID: 11208453
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Angiogenesis in embryos and ischemic diseases.
    Breier G; Damert A; Plate KH; Risau W
    Thromb Haemost; 1997 Jul; 78(1):678-83. PubMed ID: 9198238
    [TBL] [Abstract][Full Text] [Related]  

  • 5. VEGFs, receptors and angiogenesis.
    Veikkola T; Alitalo K
    Semin Cancer Biol; 1999 Jun; 9(3):211-20. PubMed ID: 10343072
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel vascular endothelial growth factor encoded by Orf virus, VEGF-E, mediates angiogenesis via signalling through VEGFR-2 (KDR) but not VEGFR-1 (Flt-1) receptor tyrosine kinases.
    Meyer M; Clauss M; Lepple-Wienhues A; Waltenberger J; Augustin HG; Ziche M; Lanz C; Büttner M; Rziha HJ; Dehio C
    EMBO J; 1999 Jan; 18(2):363-74. PubMed ID: 9889193
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vascular endothelial growth factor and the regulation of angiogenesis.
    Ferrara N
    Recent Prog Horm Res; 2000; 55():15-35; discussion 35-6. PubMed ID: 11036931
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of vascular endothelial growth factor (VEGF) as a novel approach for cancer therapy.
    Wood JM
    Medicina (B Aires); 2000; 60 Suppl 2():41-7. PubMed ID: 11188930
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vascular endothelial growth factor (VEGF) receptor-2 antagonists inhibit VEGF- and basic fibroblast growth factor-induced angiogenesis in vivo and in vitro.
    Tille JC; Wood J; Mandriota SJ; Schnell C; Ferrari S; Mestan J; Zhu Z; Witte L; Pepper MS
    J Pharmacol Exp Ther; 2001 Dec; 299(3):1073-85. PubMed ID: 11714897
    [TBL] [Abstract][Full Text] [Related]  

  • 10. VEGF receptor signal transduction.
    Matsumoto T; Claesson-Welsh L
    Sci STKE; 2001 Dec; 2001(112):re21. PubMed ID: 11741095
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular biology of the VEGF and the VEGF receptor family.
    Clauss M
    Semin Thromb Hemost; 2000; 26(5):561-9. PubMed ID: 11129413
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Angiogenesis--vascular endothelial growth factor and its receptors].
    Shibuya M
    Hum Cell; 1999 Mar; 12(1):17-24. PubMed ID: 10457901
    [TBL] [Abstract][Full Text] [Related]  

  • 13. KDR/Flk-1 is a major regulator of vascular endothelial growth factor-induced tumor development and angiogenesis in murine hepatocellular carcinoma cells.
    Yoshiji H; Kuriyama S; Hicklin DJ; Huber J; Yoshii J; Miyamoto Y; Kawata M; Ikenaka Y; Nakatani T; Tsujinoue H; Fukui H
    Hepatology; 1999 Nov; 30(5):1179-86. PubMed ID: 10534339
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Possible involvement of VEGF-FLT tyrosine kinase receptor system in normal and tumor angiogenesis.
    Shibuya M; Seetharam L; Ishii Y; Sawano A; Gotoh N; Matsushime H; Yamaguchi S
    Princess Takamatsu Symp; 1994; 24():162-70. PubMed ID: 8983073
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Lymphangiogenesis and biological activity ov vascular endothelial growth factor-C].
    Mandriota SJ; Pepper MS
    J Soc Biol; 1999; 193(2):159-63. PubMed ID: 10451350
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overexpression of vascular endothelial growth factor in the avian embryo induces hypervascularization and increased vascular permeability without alterations of embryonic pattern formation.
    Flamme I; von Reutern M; Drexler HC; Syed-Ali S; Risau W
    Dev Biol; 1995 Oct; 171(2):399-414. PubMed ID: 7556923
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Two independent mechanisms essential for tumor angiogenesis: inhibition of human melanoma xenograft growth by interfering with either the vascular endothelial growth factor receptor pathway or the Tie-2 pathway.
    Siemeister G; Schirner M; Weindel K; Reusch P; Menrad A; Marmé D; Martiny-Baron G
    Cancer Res; 1999 Jul; 59(13):3185-91. PubMed ID: 10397264
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glioblastoma growth inhibited in vivo by a dominant-negative Flk-1 mutant.
    Millauer B; Shawver LK; Plate KH; Risau W; Ullrich A
    Nature; 1994 Feb; 367(6463):576-9. PubMed ID: 8107827
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of angiogenesis via vascular endothelial growth factor receptors.
    Veikkola T; Karkkainen M; Claesson-Welsh L; Alitalo K
    Cancer Res; 2000 Jan; 60(2):203-12. PubMed ID: 10667560
    [No Abstract]   [Full Text] [Related]  

  • 20. PTK787/ZK 222584, a novel and potent inhibitor of vascular endothelial growth factor receptor tyrosine kinases, impairs vascular endothelial growth factor-induced responses and tumor growth after oral administration.
    Wood JM; Bold G; Buchdunger E; Cozens R; Ferrari S; Frei J; Hofmann F; Mestan J; Mett H; O'Reilly T; Persohn E; Rösel J; Schnell C; Stover D; Theuer A; Towbin H; Wenger F; Woods-Cook K; Menrad A; Siemeister G; Schirner M; Thierauch KH; Schneider MR; Drevs J; Martiny-Baron G; Totzke F
    Cancer Res; 2000 Apr; 60(8):2178-89. PubMed ID: 10786682
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.